Dr. Studts discusses why LDCT screening has been an underused resource despite reducing lung cancer mortality by twenty percent.
The inspiration for this gift was the dedication, selflessness, and overall outstanding patient care provided by Drs. Chris Lieu and Jennifer Diamond.
Antonio Jimeno, MD, PhD, is working on a study to investigate disparities in clinical trials and increase the representation of underserved populations.
We are pleased to announce the promotion of Dr. Stephen Keysar from Assistant Research Professor to Associate Research Professor.
Dr. Camidge has participated in one of the largest efforts to prove that MET-inhibitor drugs are effective for treating patients with NSCLC driven by MET amplification.
Traci Lyons, PhD, suggests semaphorin 7 may be particularly important in estrogen receptor (ER) positive breast cancer because cancer cells in ER-positive breast cancer have receptors that allow them to use the hormone estrogen to grow.